The Board of directors of Adani Ports and Special Economic Zone Limited has recommended a Dividend Rs. 7/- (@ 350%) per equity share of Rs. 2/- each fully paid-up for the financial year 2024-25, ...

IOL Chemicals and Pharmaceuticals Limited's product, "Ibuprofen," has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China.

The company has reported total income of Rs. 500.80 crores during the period ended March 31, 2025 as compared to Rs. 483.54 crores during the period ended December 31, 2024. The company has posted ...

The company has reported total income of Rs. 1798.2 crores during the period ended March 31, 2025 as compared to Rs. 1784.9 crores during the period ended December 31, 2024. The company has posted ...

The company has reported total income of Rs. 463.81 crores during the period ended March 31, 2025 as compared to Rs. 478.44 crores during the period ended December 31, 2024. The company has posted ...

The company has reported total income of Rs. 84.35 crores during the period ended March 31, 2025 as compared to Rs. 66.43 crores during the period ended December 31, 2024. The company has posted ...

The company has reported total income of Rs. 1960.71 crores during the period ended March 31, 2025 as compared to Rs. 1855.10 crores during the period ended December 31, 2024. The company has ...

The company has reported total income of Rs. 4477.91 crores during the period ended March 31, 2025 as compared to Rs. 4610.47 crores during the period ended December 31, 2024. The company has ...

The Board of Directors of NELCO Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2025 - Q4FY25, Q4FY2025, FY2024-25, FY2025.

The Board of Directors of Axis Bank Limited, at its meeting held today have approved the financial results of the company for ...

The Board of Directors of Adani Energy Solutions Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2025 - Q4FY25, Q4FY2025, FY2024-25 ...